Astrana Health, Inc. (ASTH)
(Real Time Quote from BATS)
$48.82 USD
-0.51 (-1.03%)
Updated Jul 22, 2024 11:12 AM ET
4-Sell of 5 4
C Value F Growth A Momentum C VGM
Price, Consensus and EPS Surprise
ASTH 48.82 -0.51(-1.03%)
Will ASTH be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ASTH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ASTH
Here is Why Growth Investors Should Buy Astrana Health, Inc. (ASTH) Now
DaVita HealthCare (DVA) Surpasses Q1 Earnings and Revenue Estimates
ASTH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Option Care (OPCH) Q1 Earnings and Revenues Surpass Estimates
Astrana Health Inc. (ASTH) Q4 Earnings and Revenues Top Estimates
Other News for ASTH
Astrana Health and Elation Health Form Nationwide Partnership to Expand Sustainable Support Infrastructure for Primary Care Physicians
Astrana Health and Elation Health announce partnership
Astrana Health and Elation Health partner in infrastructure solution
Astrana Health and Anthem Blue Cross Establish Partnership to Deliver High-Quality Coordinated Care
Astrana Health price target raised to $48 from $45 at Stifel